Efficacy and Safety of Electroconvulsive Therapy

Displaying 1 - 3 of 3CSV
Laroy, M., Bouckaert, F., Ousdal, O. T., Dols, A., Rhebergen, D., van Exel, E., van Wingen, G., van Waarde, J., Verdijk, J., Kessler, U., Bartsch, H., Jorgensen, M. B., Paulson, O. B., Nordanskog, P., Prudic, J., Sienaert, P., Vandenbulcke, M., Oltedal, L., & Emsell, L. (2024). Characterization of gray matter volume changes from one week to 6 months after termination of electroconvulsive therapy in depressed patients. Brain Stimulation, 17(4), 876–886. https://doi.org/10.1016/j.brs.2024.07.015
Publication Date
Sajid, S., Lawrence, R. E., Galfalvy, H. C., Keilp, J. G., Moitra, V. K., Mann, J. J., & Grunebaum, M. F. (2024). Intramuscular ketamine vs. midazolam for rapid risk-reduction in suicidal, depressed emergency patients: Clinical trial design and rationale. Journal of Affective Disorders Reports, 15, 100690. https://doi.org/10.1016/j.jadr.2023.100690
Publication Date